DEC 29, 2020 11:17 AM PST

How CRISPR Can Help Create a Vaccine for a Common Parasite

WRITTEN BY: Carmen Leitch

The parasite Toxoplasma gondii is thought to infect a third of the people on the planet as well as the majority of warm-blooded animals including domestic cats. While these parasitic infections don’t usually cause serious illness in people, they can be dangerous to people with weak immune systems, causes disease in the developing fetus, and can be detrimental to livestock. Reporting in the Journal of Biological Methods, researchers are trying to use CRISPR to aid in the development of a vaccine for the common parasite.

Image credit: Modified from ubyquit/Pixabay

The live cycle of T. gondii is complex. After infecting cats, it enters a pathogenic stage and is shed in cat feces as encapsulated oocysts. Those oocysts can then move into the environment where they become infectious and contaminate food that is then eaten by other animals or humans, or get transferred into the air and inhaled when someone is changing a litter box. 

The CRISPR-Cas9 technique can make changes to individual bases in the genomes of single-celled organisms like the T. gondii parasite, in this case, to render it non-pathogenic. This will allow the investigators to create a live vaccine using a harmless version of the parasite.

"If we succeed in preventing the production of these oocysts, we can reduce the occurrence of toxoplasmosis among humans and animals," noted Adrian Hehl, professor of parasitology at the University of Zurich's Vetsuisse Faculty. 

Previous work by Hehl’s team identified the genes that are involved in oocyst formation in T. gondii. They used CRISPR-Cas9 to disable these genes, then exposed cats to these modified parasites. The idea is that cats will naturally gain protection from further T. gondii infections, but will not be able to pass on the infectious oocysts.

In this work, the researchers used an alternate version of CRISPR-Cas9 that does not involve generating something called a plasmid. In many cases, the plasmid carries all of the CRISPR-Cas9 tools on it, but it sticks around in cells after the edits are made, where it can have unwanted effects. Alternative strategies involve using much smaller, more transient pieces of genetic material that don’t hang around after the CRISPR-Cas9 edit is made. Hehl’s team and other groups have created more efficient methods that cost less and take less time.

"Our approach isn't just quicker, cheaper, and more efficient than conventional methods. It also enables the genomic sequence to be altered without leaving traces in the cell," explains Hehl. "This means we can now manufacture experimental live vaccines without plasmids or building in resistance genes."


Sources: Phys.org via University of Zurich, Journal of Biological Methods

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 08, 2021
Cell & Molecular Biology
How Viruses Keep the Infection Going
JAN 08, 2021
How Viruses Keep the Infection Going
There has long been debate about whether viruses are a form of life, because many of them are only made up of a bit of g ...
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
FEB 01, 2021
Microbiology
A Potential Leptospirosis Vaccine is Created
FEB 01, 2021
A Potential Leptospirosis Vaccine is Created
Spirochetes are a type of free-living, spiral-shaped bacteria, some of which are harmless and others that can cause dise ...
MAR 21, 2021
Microbiology
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
MAR 21, 2021
Potent Drug Rapidly Clears Drug-Resistant Gonorrhea in Mouse Model
A mouse model has shown that it's possible to clear a multi-drug resistant gonorrhea with only one dose of antibioti ...
MAR 30, 2021
Microbiology
A Marburg Virus Treatment Approach is Identified
MAR 30, 2021
A Marburg Virus Treatment Approach is Identified
Marburg virus causes severe hemorrhagic fever; its fatality ratio can be as high as 88 percent. Researchers may have now ...
APR 13, 2021
Microbiology
Learning How TORCH Pathogens Cause Brain Malformations
APR 13, 2021
Learning How TORCH Pathogens Cause Brain Malformations
The term TORCH pathogens refers to a group of viruses including Toxoplasma gondii, Rubella, Herpes Simplex Viruses 1 and ...
Loading Comments...